891 filings
Page 5 of 45
SC 13G
Fletcher Aaron G.L.
17 Jan 23
Aptose Biosciences / Fletcher Aaron G.L. ownership change
6:05am
8-K
APTO
Aptose Biosciences Inc
6 Jan 23
Financial Statements and Exhibits
8:48am
8-K
APTO
Aptose Biosciences Inc
12 Dec 22
Entry into a Material Definitive Agreement
8:00am
424B5
APTO
Aptose Biosciences Inc
9 Dec 22
Prospectus supplement for primary offering
6:59pm
8-K
APTO
Aptose Biosciences Inc
9 Dec 22
Other Events
6:48pm
8-K
APTO
Aptose Biosciences Inc
7 Dec 22
Aptose to Hold Clinical Update and Data Review of AML Drug Tuspetinib on Sunday, December 11th
4:15pm
424B5
APTO
Aptose Biosciences Inc
29 Nov 22
Prospectus supplement for primary offering
4:43pm
8-K
APTO
Aptose Biosciences Inc
25 Nov 22
Termination of a Material Definitive Agreement
4:30pm
8-K
APTO
Aptose Biosciences Inc
14 Nov 22
Regulation FD Disclosure
7:35am
8-K
APTO
Aptose Biosciences Inc
3 Nov 22
Aptose Clinical Data to be Presented at the 2022 ASH Annual Meeting
9:10am
10-Q
2022 Q3
APTO
Aptose Biosciences Inc
Quarterly report
1 Nov 22
4:15pm
8-K
APTO
Aptose Biosciences Inc
1 Nov 22
Aptose Reports Results for the Third Quarter 2022
4:01pm
EFFECT
APTO
Aptose Biosciences Inc
24 Oct 22
Notice of effectiveness
12:15am
424B2
APTO
Aptose Biosciences Inc
21 Oct 22
Prospectus for primary offering
5:15pm
CORRESP
APTO
Aptose Biosciences Inc
19 Oct 22
Correspondence with SEC
12:00am
UPLOAD
APTO
Aptose Biosciences Inc
19 Oct 22
Letter from SEC
12:00am
S-3
APTO
Aptose Biosciences Inc
Shelf registration
7 Oct 22
6:10pm
4
Rice William G.
21 Sep 22
Aptose Biosciences / William G. Rice ownership change
6:07pm
4
Fletcher Payne
21 Sep 22
Aptose Biosciences / Fletcher Payne ownership change
6:06pm
4
APTO
Aptose Biosciences Inc
16 Sep 22
Aptose Biosciences / Bernd R. Seizinger ownership change
5:32pm